Astellas Pharma Inc. Newsletter
-
Asthma and COPD Drugs Market 2025: Strategic Insights for Growth, Expansion, and Gaining Competitive Edge
04 Jul 2025 10:19 GMT
… Company, Amgen, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Astellas Pharma, AptarGroup, Chiesi Farmaceutici … By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores
Furthermore, there are …
-
New R&D head at Astellas touts Cambridge drug research center
03 Jul 2025 16:55 GMT
-
Genitourinary Drugs Market 2025–2034: In-Depth Forecast on Size, Growth Drivers, Trends & Competitive Outlook
02 Jul 2025 13:22 GMT
… Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Ipsen Société Anonyme … Distribution Channel: Hospital Pharmacies, Drug Store And Retail Pharmacies, Online Pharmacies
Where additions to …
-
Castration-Resistant Prostate Cancer CRPC or Hormone-Refractory Prostate Cancer HRPCA Therapeutics Market Report 2025
04 Jul 2025 16:49 GMT
… , AstraZeneca plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Co … Research Company:
Prostate Cancer Drugs Global Market Report 2025
https … 47;report/prostate-cancer-drugs-global-market-report
Urothelial Carcinoma …
-
AZ claims EU okay for Imfinzi in bladder cancer
04 Jul 2025 12:48 GMT
… ) and Astellas/Pfizer's anti-Nectin-4 drug Padcev (enfortumab …
-
Incretin-Based Drugs Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
01 Jul 2025 10:51 GMT
… Viatris, Boehringer Ingelheim GmbH, Astellas Pharma Inc., Daiichi Sankyo Company Limited … The Business Research Company:
Pharmaceutical Drug Delivery Global Market Report … com/report/pharmaceutical-drug-delivery-global-market-report
…
-
Astellas Korea appoints ex-Daiichi Sankyo exec as market access head
01 Jul 2025 08:31 GMT
… of global life sciences company Astellas Pharma, said it has named … Astellas Korea’s portfolio of innovative medicines, including antibody-drug … expert.
“True value in drug development is only realized when … patients who need it,” Astellas Korea CEO Kim Jun-il …
-
Drugs to treat GA: Yes, please!
30 Jun 2025 16:36 GMT
… (AMD). The advantages of these drugs may outweigh the disadvantages, according … scientific advisor for Apellis Pharmaceuticals, Alexion, Annexon Biosciences, Astellas Pharma US, Complement Therapeutics …
-
Top Growth Driver in the Bone Pain Treatment Market 2025: The Increasing Prevalence Of Osteoporosis
04 Jul 2025 10:21 GMT
… .V., Astellas Pharma Inc., Endo International plc, Amneal Pharmaceuticals Inc., Marksans Pharma Limited, and … Business Research Company:
Pain Management Drugs Global Market Report 2025
https …
-
Immunomodulator Therapeutics Global Market Research 2024-2030 | R&D Investments Fuel Next-Gen Immunomodulator Development Amid Patent Expiry - ResearchAndMarkets.com
04 Jul 2025 10:58 GMT
… primary market drivers and restraints, drug development trends, partnerships, and … Pharmaceuticals
Vera Therapeutics
Rigel Pharmaceuticals
Astellas Pharma
Takeda
Chugai Pharma
Mitsubishi Chemical
Sun Pharmaceutical Industries
Shanghai Pharmaceuticals …
About
© 1995-2025